Year |
Citation |
Score |
2013 |
Boulay D, Ho-Van S, Bergis O, Avenet P, Griebel G. Phencyclidine decreases tickling-induced 50-kHz ultrasound vocalizations in juvenile rats: a putative model of the negative symptoms of schizophrenia? Behavioural Pharmacology. 24: 543-51. PMID 23928693 DOI: 10.1097/FBP.0b013e3283654044 |
0.334 |
|
2011 |
Boulay D, Depoortere R, Louis C, Lacave M, Lucas MT, Griebel G. SSR181507, a dopamine Dâ‚‚ receptor and 5-HT(â‚A) receptor ligand: evidence for mixed anxiolytic- and antidepressant-like activities. Pharmacology, Biochemistry, and Behavior. 97: 428-35. PMID 20920519 DOI: 10.1016/j.pbb.2010.09.019 |
0.32 |
|
2008 |
Boulay D, Pichat P, Dargazanli G, Estenne-Bouhtou G, Terranova JP, Rogacki N, Stemmelin J, Coste A, Lanneau C, Desvignes C, Cohen C, Alonso R, Vigé X, Biton B, Steinberg R, et al. Characterization of SSR103800, a selective inhibitor of the glycine transporter-1 in models predictive of therapeutic activity in schizophrenia. Pharmacology, Biochemistry, and Behavior. 91: 47-58. PMID 18621075 DOI: 10.1016/j.pbb.2008.06.009 |
0.333 |
|
2005 |
Depoortère R, Dargazanli G, Estenne-Bouhtou G, Coste A, Lanneau C, Desvignes C, Poncelet M, Heaulme M, Santucci V, Decobert M, Cudennec A, Voltz C, Boulay D, Terranova JP, Stemmelin J, et al. Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-1 SSR504734, a potential new type of antipsychotic. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 1963-85. PMID 15956994 DOI: 10.1038/sj.npp.1300772 |
0.385 |
|
2004 |
Boulay D, Depoortère R, Louis C, Perrault G, Griebel G, Soubrié P. SSR181507, a putative atypical antipsychotic with dopamine D2 antagonist and 5-HT1A agonist activities: improvement of social interaction deficits induced by phencyclidine in rats. Neuropharmacology. 46: 1121-9. PMID 15111019 DOI: 10.1016/j.neuropharm.2004.02.008 |
0.4 |
|
2003 |
Depoortere R, Boulay D, Perrault G, Bergis O, Decobert M, Françon D, Jung M, Simiand J, Soubrié P, Scatton B. SSR181507, a dopamine D2 receptor antagonist and 5-HT1A receptor agonist. II: Behavioral profile predictive of an atypical antipsychotic activity. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 1889-902. PMID 12902993 DOI: 10.1038/sj.npp.1300261 |
0.339 |
|
2001 |
Naudon L, Leroux-Nicollet I, Boulay D, Costentin J. Decreased densities of dopamine and serotonin transporters and of vesicular monoamine transporter 2 in severely kainic acid lesioned subregions of the striatum. Journal of Neural Transmission (Vienna, Austria : 1996). 108: 431-44. PMID 11475010 DOI: 10.1007/S007020170064 |
0.674 |
|
2000 |
Boulay D, Depoortere R, Oblin A, Sanger DJ, Schoemaker H, Perrault G. Haloperidol-induced catalepsy is absent in dopamine D(2), but maintained in dopamine D(3) receptor knock-out mice. European Journal of Pharmacology. 391: 63-73. PMID 10720636 DOI: 10.1016/S0014-2999(99)00916-4 |
0.476 |
|
2000 |
Boulay D, Depoortere R, Perrault G, Sanger DJ. Decreased locomotor activity after microinjection of dopamine D2/D3 receptor agonists and antagonists into lobule 9/10 of the cerebellum: a D3 receptor mediated effect? Progress in Neuro-Psychopharmacology & Biological Psychiatry. 24: 39-49. PMID 10659982 DOI: 10.1016/S0278-5846(99)00079-2 |
0.437 |
|
1999 |
Boulay D, Depoortere R, Perrault G, Borrelli E, Sanger DJ. Dopamine D2 receptor knock-out mice are insensitive to the hypolocomotor and hypothermic effects of dopamine D2/D3 receptor agonists. Neuropharmacology. 38: 1389-96. PMID 10471093 DOI: 10.1016/S0028-3908(99)00064-7 |
0.338 |
|
1999 |
Boulay D, Depoortere R, Rostene W, Perrault G, Sanger DJ. Dopamine D3 receptor agonists produce similar decreases in body temperature and locomotor activity in D3 knock-out and wild-type mice. Neuropharmacology. 38: 555-65. PMID 10221759 DOI: 10.1016/S0028-3908(98)00213-5 |
0.337 |
|
1999 |
Boulay D. DA D2, BUT NOT D3 KNOCK-OUT MICE, SHOW A DEFICIT OF ACQUISITION OF ACTIVE AVOIDANCE, AND ARE INSENSITIVE TO THE EFFECTS OF HALOPERIDOL ON THE PERFORMANCE OF ACTIVE AVOIDANCE Behavioural Pharmacology. 10: S10. DOI: 10.1097/00008877-199908001-00024 |
0.309 |
|
1996 |
Boulay D, Duterte-Boucher D, Leroux-Nicollet I, Naudon L, Costentin J. Locomotor sensitization and decrease in [3H]mazindol binding to the dopamine transporter in the nucleus accumbens are delayed after chronic treatments by GBR12783 or cocaine. The Journal of Pharmacology and Experimental Therapeutics. 278: 330-7. PMID 8764367 |
0.669 |
|
1996 |
Boulay D, Duterte-Boucher D, Nouel D, Costentin J. Locomotor sensitization to [D-Trp(11)]neurotensin after repeated injections of the dopamine uptake inhibitor GBR12783 in rats. Neuroscience Letters. 208: 5-8. PMID 8731161 DOI: 10.1016/0304-3940(96)12531-3 |
0.59 |
|
1994 |
Boulay D, Leroux-Nicollet I, Duterte-Boucher D, Naudon L, Costentin J. Invariance of the density of dopamine uptake sites and dopamine metabolism in the rat brain after a chronic treatment with the dopamine uptake inhibitor GBR 12783. Journal of Neural Transmission. General Section. 98: 209-15. PMID 7748521 DOI: 10.1007/Bf01276537 |
0.609 |
|
Show low-probability matches. |